Compounds > foscarnet

foscarnet and fosfomycin

foscarnet has been researched along with fosfomycin in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (35.71)	29.6817
2010's	8 (57.14)	24.3611
2020's	1 (7.14)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Campillo, NE; Guerra, A; Páez, JA	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Csanaky, I; Gregus, Z	1
Armstrong, RN; Fillgrove, KL; Newcomer, ME; Rife, CL; Rigsby, RE	1
Arakawa, Y; Jin, W; Kawamura, K; Kimura, K; Nakamura, G; Sato, N; Shibayama, K; Wachino, J; Yagi, T; Yamada, K	1
Cooper, VS; Doi, Y; Guo, Q; McElheny, CL; Sluis-Cremer, N; Stoesser, N; Tomich, AD; Wang, M	1
Arlet, G; Benzerara, Y; Decré, D; Gallah, S; Genel, N; Hommeril, B; Rottman, M	1
Doi, Y; Ito, R; McElheny, CL; Mettus, RT; Sluis-Cremer, N; Tomich, AD	1
Garneau-Tsodikova, S; Gilbert, NC; Green, KD; Thompson, MK; Travis, S; Tsodikov, OV	1

Reviews

1 review(s) available for foscarnet and fosfomycin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

13 other study(ies) available for foscarnet and fosfomycin

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Neural computational prediction of oral drug absorption based on CODES 2D descriptors. European journal of medicinal chemistry, 2010, Volume: 45, Issue:3 Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR. European journal of medicinal chemistry, 2011, Volume: 46, Issue:1 Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics	2011
Effect of phosphate transporter and methylation inhibitor drugs on the disposition of arsenate and arsenite in rats. Toxicological sciences : an official journal of the Society of Toxicology, 2001, Volume: 63, Issue:1 Topics: Arsenates; Arsenites; Biotransformation; Carrier Proteins; Catechols; Foscarnet; Fosfomycin; Methylation; Nitriles; Nitrous Oxide; Phosphates; Tissue Distribution	2001
Phosphonoformate: a minimal transition state analogue inhibitor of the fosfomycin resistance protein, FosA. Biochemistry, 2004, Nov-02, Volume: 43, Issue:43 Topics: Bacterial Proteins; Binding Sites; Catalysis; Crystallization; Crystallography, X-Ray; Drug Resistance, Bacterial; Foscarnet; Fosfomycin; Glutathione Transferase; Kinetics; Manganese; Organophosphonates; Pseudomonas aeruginosa	2004
Practical agar-based disk potentiation test for detection of fosfomycin-nonsusceptible Escherichia coli clinical isolates producing glutathione S-transferases. Journal of clinical microbiology, 2014, Volume: 52, Issue:9 Topics: Agar; Anti-Bacterial Agents; Culture Media; DNA, Bacterial; Drug Tolerance; Escherichia coli; Escherichia coli Infections; Foscarnet; Fosfomycin; Glutathione Transferase; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Sequence Analysis, DNA	2014
Glutathione-S-transferase FosA6 of Klebsiella pneumoniae origin conferring fosfomycin resistance in ESBL-producing Escherichia coli. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:9 Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; DNA, Bacterial; Drug Resistance, Bacterial; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Foscarnet; Fosfomycin; Genome, Bacterial; Glutathione Transferase; Humans; Kinetics; Microbial Sensitivity Tests; Plasmids; Sequence Analysis, DNA; Urine	2016
Emergence of Plasmid-Mediated Fosfomycin-Resistance Genes among Escherichia coli Isolates, France. Emerging infectious diseases, 2017, Volume: 23, Issue:9 Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Foscarnet; Fosfomycin; France; Gene Expression; Humans; Isoenzymes; Microbial Sensitivity Tests; Plasmids; Prevalence	2017
Inhibition of Fosfomycin Resistance Protein FosA by Phosphonoformate (Foscarnet) in Multidrug-Resistant Gram-Negative Pathogens. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:12 Topics: Anti-Bacterial Agents; Antiviral Agents; Drug Repositioning; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Enterobacter cloacae; Escherichia coli; Escherichia coli Proteins; Foscarnet; Fosfomycin; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Protein Isoforms; Pseudomonas aeruginosa; Recombinant Proteins	2017
Inhibition of Fosfomycin Resistance Protein FosB from Gram-Positive Pathogens by Phosphonoformate. Biochemistry, 2023, 01-03, Volume: 62, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Foscarnet; Fosfomycin; Microbial Sensitivity Tests; Staphylococcus aureus; Transferases	2023